These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

277 related articles for article (PubMed ID: 37360338)

  • 1. Microglia in the context of multiple sclerosis.
    Zhang X; Chen F; Sun M; Wu N; Liu B; Yi X; Ge R; Fan X
    Front Neurol; 2023; 14():1157287. PubMed ID: 37360338
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neuronal injury in chronic CNS inflammation.
    Zindler E; Zipp F
    Best Pract Res Clin Anaesthesiol; 2010 Dec; 24(4):551-62. PubMed ID: 21619866
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Regulatory B Cells Normalize CNS Myeloid Cell Content in a Mouse Model of Multiple Sclerosis and Promote Oligodendrogenesis and Remyelination.
    Pennati A; Nylen EA; Duncan ID; Galipeau J
    J Neurosci; 2020 Jun; 40(26):5105-5115. PubMed ID: 32430295
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Multiple sclerosis risk gene Mertk is required for microglial activation and subsequent remyelination.
    Shen K; Reichelt M; Kyauk RV; Ngu H; Shen YA; Foreman O; Modrusan Z; Friedman BA; Sheng M; Yuen TJ
    Cell Rep; 2021 Mar; 34(10):108835. PubMed ID: 33691116
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The roles of microglia and astrocytes in phagocytosis and myelination: Insights from the cuprizone model of multiple sclerosis.
    Sen MK; Mahns DA; Coorssen JR; Shortland PJ
    Glia; 2022 Jul; 70(7):1215-1250. PubMed ID: 35107839
    [TBL] [Abstract][Full Text] [Related]  

  • 6. miRNAs in Microglia: Important Players in Multiple Sclerosis Pathology.
    Walsh AD; Nguyen LT; Binder MD
    ASN Neuro; 2021; 13():1759091420981182. PubMed ID: 33517686
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Multiple Sclerosis and Aging: The Dynamics of Demyelination and Remyelination.
    Correale J; Ysrraelit MC
    ASN Neuro; 2022; 14():17590914221118502. PubMed ID: 35938615
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Multifaceted involvement of microglia in gray matter pathology in multiple sclerosis.
    Tsouki F; Williams A
    Stem Cells; 2021 Aug; 39(8):993-1007. PubMed ID: 33754376
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Molecular Basis for Remyelination Failure in Multiple Sclerosis.
    Gruchot J; Weyers V; Göttle P; Förster M; Hartung HP; Küry P; Kremer D
    Cells; 2019 Aug; 8(8):. PubMed ID: 31382620
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CSF1R signaling is a regulator of pathogenesis in progressive MS.
    Hagan N; Kane JL; Grover D; Woodworth L; Madore C; Saleh J; Sancho J; Liu J; Li Y; Proto J; Zelic M; Mahan A; Kothe M; Scholte AA; Fitzgerald M; Gisevius B; Haghikia A; Butovsky O; Ofengeim D
    Cell Death Dis; 2020 Oct; 11(10):904. PubMed ID: 33097690
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Distinct patterns of glia repair and remyelination in antibody-mediated demyelination models of multiple sclerosis and neuromyelitis optica.
    Liu Y; Given KS; Owens GP; Macklin WB; Bennett JL
    Glia; 2018 Dec; 66(12):2575-2588. PubMed ID: 30240044
    [TBL] [Abstract][Full Text] [Related]  

  • 12. TREM2-dependent microglial function is essential for remyelination and subsequent neuroprotection.
    Wang Y; Kyauk RV; Shen YA; Xie L; Reichelt M; Lin H; Jiang Z; Ngu H; Shen K; Greene JJ; Sheng M; Yuen TJ
    Glia; 2023 May; 71(5):1247-1258. PubMed ID: 36625077
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Systemic TLR2 tolerance enhances central nervous system remyelination.
    Wasko NJ; Kulak MH; Paul D; Nicaise AM; Yeung ST; Nichols FC; Khanna KM; Crocker S; Pachter JS; Clark RB
    J Neuroinflammation; 2019 Jul; 16(1):158. PubMed ID: 31351476
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Modulation of the Microglial Nogo-A/NgR Signaling Pathway as a Therapeutic Target for Multiple Sclerosis.
    Nheu D; Ellen O; Ye S; Ozturk E; Pagnin M; Kertadjaja S; Theotokis P; Grigoriadis N; McLean C; Petratos S
    Cells; 2022 Nov; 11(23):. PubMed ID: 36497029
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The role of oligodendrocytes and oligodendrocyte progenitors in CNS remyelination.
    Keirstead HS; Blakemore WF
    Adv Exp Med Biol; 1999; 468():183-97. PubMed ID: 10635029
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Protecting effect of emodin in experimental autoimmune encephalomyelitis mice by inhibiting microglia activation and inflammation via Myd88/PI3K/Akt/NF-κB signalling pathway.
    Zheng K; Lv B; Wu L; Wang C; Xu H; Li X; Wu Z; Zhao Y; Zheng Z
    Bioengineered; 2022 Apr; 13(4):9322-9344. PubMed ID: 35287559
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reduced Microglial Activity and Enhanced Glutamate Transmission in the Basolateral Amygdala in Early CNS Autoimmunity.
    Acharjee S; Verbeek M; Gomez CD; Bisht K; Lee B; Benoit L; Sharkey KA; Benediktsson A; Tremblay ME; Pittman QJ
    J Neurosci; 2018 Oct; 38(42):9019-9033. PubMed ID: 30185466
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Targeting PKC in microglia to promote remyelination and repair in the CNS.
    Kim PM; Kornberg MD
    Curr Opin Pharmacol; 2022 Feb; 62():103-108. PubMed ID: 34965482
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Remyelinating strategies: What can be learned from normal brain development.
    Shelestak J; Irfan M; DeSilva TM
    Curr Opin Pharmacol; 2022 Dec; 67():102290. PubMed ID: 36195009
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Opposing effects of apoE2 and apoE4 on microglial activation and lipid metabolism in response to demyelination.
    Wang N; Wang M; Jeevaratnam S; Rosenberg C; Ikezu TC; Shue F; Doss SV; Alnobani A; Martens YA; Wren M; Asmann YW; Zhang B; Bu G; Liu CC
    Mol Neurodegener; 2022 Nov; 17(1):75. PubMed ID: 36419137
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.